XML 33 R17.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings (Loss) Per Share
 6 Months Ended
Apr. 02, 2021
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share EARNINGS (LOSS) PER SHARE:Basic earnings (loss) per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings (loss) per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of stock awards.
The following table sets forth the computation of basic and diluted earnings (loss) per share attributable to the Company's stockholders (in thousands, except per share data):
Three Months EndedSix Months Ended
April 2, 2021March 27, 2020April 2, 2021March 27, 2020
Loss:
Net loss attributable to Aramark stockholders$(77,576)$(202,260)$(158,819)$(56,499)
Shares:
Basic weighted-average shares outstanding
254,508 252,354 254,088 250,543 
Effect of dilutive securities(1)
— — — — 
Diluted weighted-average shares outstanding
254,508 252,354 254,088 250,543 
Basic Loss Per Share:
Net loss attributable to Aramark stockholders$(0.30)$(0.80)$(0.63)$(0.23)
Diluted Loss Per Share:
Net loss attributable to Aramark stockholders$(0.30)$(0.80)$(0.63)$(0.23)

(1)
Incremental shares of 2.2 million and 2.0 million have been excluded from the computation of diluted weighted-average shares outstanding for the three and six months ended April 2, 2021, respectively, because the effect would have been antidilutive due to the net loss attributable to Aramark stockholders during both periods. Incremental shares of 2.1 million and 3.8 million have been excluded from the computation of diluted weighted-average shares outstanding for the three and six months ended March 27, 2020, respectively, because the effect would have been antidilutive due to the net loss attributable to Aramark stockholders during both periods.
Share-based awards to purchase 9.2 million and 5.0 million shares were outstanding for the three months ended April 2, 2021 and March 27, 2020, respectively, but were not included in the computation of diluted loss per common share, as their effect would have been antidilutive. In addition, PSUs related to 1.1 million and 1.7 million shares were outstanding for the three months ended April 2, 2021 and March 27, 2020, respectively, but were not included in the computation of diluted loss per common share, as the performance targets were not yet met.
Share-based awards to purchase 11.6 million and 4.1 million shares were outstanding for the six months ended April 2, 2021 and March 27, 2020, respectively, but were not included in the computation of diluted loss per common share, as their effect would have been antidilutive. In addition, PSUs related to 1.1 million and 1.7 million shares were outstanding for the six months ended April 2, 2021 and March 27, 2020, respectively, but were not included in the computation of diluted loss per common share, as the performance targets were not yet met.